News

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.

Saint Luke’s Mid America Heart Institute today announced results from the STEP HFpEF DM trial.

During Heart Month, we are talking about the risks of undiagnosed heart failure and treatment options for those with heart failure.

FOX4 talked to Ted Perez and his heart transplant surgeon, Dr. Russ Davis, about the lifelong Chiefs fan's incredible story.

Dr. Mathis is accepting new patients of all ages and has special interests in pediatrics, women’s health, in-office procedures, and sports medicine.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

AARP talked to Dr. James O'Keefe about the benefits of omega fatty acids and how much you should be consuming.

A growing body of evidence correlates shorter running sessions to significant health benefits, especially those regarding longevity and mental health.

A man from Columbia, Missouri, got a new heart and a second chance at life, marking the 1,000th heart transplant at Saint Luke's Mid America Heart Institute.